38 completed, 9 unknown, 3 terminated, 1 active not recruiting. 20 Phase 2, 8 Phase 1, 3 Phase 3, 2 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 20 | Completed 14, Unknown 3, Terminated 2, Withdrawn 1 |
| Phase 1 | 8 | Completed 7, Withdrawn 1 |
| Phase 3 | 3 | Completed 3 |
| Not applicable | 2 | Completed 2 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Cytogenetic Analysis: new trials by email Literature Review of Cytogenetic Analysis trials Research Report on Cytogenetic Analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia Cytogenetic analysis (FISH) for EZH2 gene deletion. -Real time PCR for PHF 19 gene expression. - Acute Myeloid Leukemia | Unknown | Assiut University | 80 | 2020-01-01 | 2020-01-03 | |
| Evaluation of Inflammatory Markers and Periodontal Viruses on Periodontitis Patients With CAD Molecular analysis - Periodontitis, Coronary Artery Disease | Unknown | Meenakshi Ammal Dental College and Hospital | 240 | 2018-11-15 | 2020-02-20 | |
| Genomic Instability in Vascular Surgeons Cytogenetic analysis - Cytogenetic Abnormality, Radiation Exposure | Completed | Hospital Clínico Universitario de Valladolid | 28 | 2018-11-09 | 2020-04-27 | |
| Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY JNJ-56022473, Bone marrow analyses and CBC with differential, Flow cytometry analyses - Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | Phase 2 | Terminated | GWT-TUD GmbH | 25 | 2016-07-01 | 2018-10-25 |
| Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 cytogenetic analysis, flow cytometry, fluorescence activated cell sorting - Leukemia | Completed | ECOG-ACRIN Cancer Research Group | 225 | 2012-04-17 | 2017-05-17 | |
| Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia cytogenetic analysis, nucleic acid sequencing, diagnostic laboratory biomarker analysis - Leukemia | Completed | Children's Oncology Group | 12 | 2012-02-01 | 2016-05-18 | |
| Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia RNA analysis, cytogenetic analysis, microarray analysis - Leukemia | Completed | Eastern Cooperative Oncology Group | 186 | 2012-01-06 | 2017-05-17 | |
| Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma DNA analysis, RNA analysis, cytogenetic analysis - Lymphoma, Nonneoplastic Condition | Completed | Children's Oncology Group | 50 | 2011-12-01 | 2016-05-17 | |
| Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms DNA analysis, cytogenetic analysis, gene mapping - Lymphoma | Completed | Eastern Cooperative Oncology Group | 32 | 2011-06-28 | 2017-05-17 | |
| Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer DNA analysis, cytogenetic analysis, gene expression analysis - Brain and Central Nervous System Tumors, Hereditary Wilms Tumor | Completed | Children's Oncology Group | 31 | 2011-05-01 | 2016-07-11 | |
| Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia cytogenetic analysis, HUMARA assay, fluorescence activated cell sorting - Leukemia | Completed | Children's Oncology Group | 20 | 2010-10-01 | 2016-07-11 | |
| Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome flow cytometry, DNA methylation analysis, cytogenetic analysis - Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 25 | 2010-07-01 | 2019-03-04 |
| Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia hydroxychloroquine, imatinib mesylate, cytogenetic analysis - Leukemia | Phase 2 | Unknown | Lynn McMahon | 66 | 2010-03-01 | 2011-11-30 |
| Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer bevacizumab, cetuximab, fluorouracil - Colorectal Cancer | Phase 2 / Phase 3 | Completed | Medical Research Council | 3240 | 2009-07-01 | 2013-12-19 |
| Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia imatinib mesylate, nilotinib, cytogenetic analysis - Leukemia | Phase 2 | Completed | Gruppo Italiano Malattie EMatologiche dell'Adulto | 129 | 2009-02-09 | 2022-01-04 |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia clofarabine, daunorubicin hydrochloride, cytogenetic analysis - Leukemia | Phase 2 | Terminated | Roswell Park Cancer Institute | 21 | 2008-12-01 | 2016-08-17 |
| Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia nilotinib, cytogenetic analysis, mutation analysis - Leukemia | Phase 2 | Completed | Cancer Trials Ireland | 40 | 2008-10-01 | 2018-07-24 |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 / Phase 2 | Withdrawn | University of Nebraska | 2008-09-01 | 2023-08-14 | |
| Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia dasatinib, vorinostat, cytogenetic analysis - Leukemia | Phase 1 | Completed | City of Hope Medical Center | 5 | 2008-09-01 | 2012-07-17 |
| CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7 pegfilgrastim, rituximab, cyclophosphamide - Leukemia | Phase 2 | Completed | Cancer Trials Ireland | 52 | 2008-08-18 | 2025-07-08 |
Showing 20 of 52. Sign in to see all of them.
Leukemia (19) · Leukemia, Myeloid, Acute (14) · Congenital Abnormalities (10) · Myelodysplastic Syndromes (10) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (8) · Leukemia, Myeloid, Chronic-Phase (6) · Leukemia, Myelomonocytic, Chronic (6) · Leukemia, Lymphocytic, Chronic, B-Cell (5) · Lymphoma (5) · Multiple Myeloma (5) · Myeloproliferative Disorders (5) · Anemia, Refractory, with Excess of Blasts (4) · Blast Crisis (4) · Breast Neoplasms (4) · Leukemia, Erythroblastic, Acute (4)
Children's Oncology Group (7) · Alliance for Clinical Trials in Oncology (5) · SWOG Cancer Research Network (4) · City of Hope Medical Center (3) · Fred Hutchinson Cancer Center (3) · Cancer Trials Ireland (2) · Case Comprehensive Cancer Center (2) · Eastern Cooperative Oncology Group (2) · Roswell Park Cancer Institute (2) · Royal Marsden NHS Foundation Trust (2) · University of Nebraska (2) · Assiut University (1) · ECOG-ACRIN Cancer Research Group (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · GWT-TUD GmbH (1)
United States (24) · United Kingdom (6) · Germany (3) · Australia (2) · Ireland (2) · Belgium (1) · Canada (1) · France (1) · India (1) · Israel (1) · Italy (1) · Spain (1)
Brenda Cooper, MD (2) · Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng) (2) · Adolfo A. Ferrando, MD, PhD (1) · Ahmad Awada, MD, PhD (1) · Alan K. Burnett, MD, FRCP (1) · Andrew Rezvani (1) · B. Douglas Smith, MD (1) · Barbara Murphy, MD (1) · Bart Scott (1) · Beverly J. Lange, MD (1) · Carlo M. Croce, MD (1) · Carolyn A. Felix, MD (1) · Clara Bloomfield, MD (1) · Dana A. Hill, MD (1) · David Kaplan, MD, PhD (1)
PMID 10339508, PMID 10577848, PMID 12370753, PMID 12393746, PMID 15020610, PMID 15124687, PMID 15197203, PMID 15368330, PMID 15534356, PMID 16522815, PMID 17157333, PMID 18039723, PMID 18082557, PMID 19560006, PMID 20020300, PMID 20093507, PMID 20723835, PMID 21147004, PMID 22989664, PMID 23871303, PMID 24144643, PMID 24156970, PMID 24440812, PMID 24966273, PMID 25361995, PMID 25476871, PMID 25621498, PMID 25818982, PMID 26468228, PMID 26902938, PMID 27272147, PMID 27470602, PMID 28127123, PMID 28925785, PMID 29577646, PMID 29705904, PMID 30028182, PMID 30322344, PMID 31232047, PMID 31267420, PMID 31375516, PMID 32816893, PMID 34162404, PMID 34847232, PMID 36823396, PMID 37196637, PMID 37483128, PMID 38017103, PMID 38702786, PMID 39283025
U10CA032102 (4), P01CA018029 (2), P01HL036444 (2), P30CA033572 (2), P30CA036727 (2), U10CA031946 (2), 2008 (1), K23HL084054 (1), P01CA078902 (1), P30CA006973 (1), P30CA014520 (1), P30CA069533 (1), P30CA093373 (1), U10CA076001 (1), U10CA180821 (1)